Evidence map›Paper›PMID 34641460›Full record

ReviewMolecules (Basel, Switzerland)2021

Advances of Microneedles in Biomedical Applications.

Jie Xu, Danfeng Xu, Xuan Xuan, Huacheng He

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 126 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jie XuDepartment of Dermatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Danfeng XuAllergy Center, Department of Dermatology, Zhejiang Provincial People's Hospital Affiliated People's Hospital Hangzhou Medical College, Hangzhou 310014, China.
Xuan XuanDepartment of Dermatology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
Huacheng HeKey Laboratory of Biotechnology and Pharmaceutical Engineering, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou 325035, China.ORCID 0000-0001-5177-0636
Wenzhou Medical University · CNZhejiang Provincial People's Hospital · CN

Funding

Wenzhou Municipal Science & Technology Bureau of China Y20180149
6 · The paper itself

Abstract

A microneedle (MN) is a painless and minimally invasive drug delivery device initially developed in 1976. As microneedle technology evolves, microneedles with different shapes (cone and pyramid) and forms (solid, drug-coated, hollow, dissolvable and hydrogel-based microneedles) have been developed. The main objective of this review is the applications of microneedles in biomedical areas. Firstly, the classifications and manufacturing of microneedle are briefly introduced so that we can learn the advantages and fabrications of different MNs. Secondly, research of microneedles in biomedical therapy such as drug delivery systems, diagnoses of disease, as well as wound repair and cancer therapy are overviewed. Finally, the safety and the vision of the future of MNs are discussed.

Indexed as

Drug Delivery SystemsAnimalsHumansMicroinjectionsNeedlesPharmaceutical PreparationsPharmaceutical Preparationsbiomedical applicationclassificationmanufacturemicroneedlepitfalls

Identifiers

PMID34641460
PMCPMC8512585
OpenAlexW3203664410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.